Opus Iii-Vii Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Opus Iii-Vii

Access the complete profile.

Opus Iii-Vii Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	339113 Surgical Appliance & Supplies Manufacturing
Address	8939 F Street Omaha, NE 68127

Note: Revenues for privately held companies are statistical evaluations.


Opus Iii-Vii's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Opus Iii-Vii's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Opus Iii-Vii is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Opus Iii-Vii Annual Revenue and Growth Rate

Opus Iii-Vii	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Opus Iii-Vii's revenues are gauged from an analysis of company filings.

Opus Iii-Vii's Income Statement (based on Industry Averages)

Opus Iii-Vii P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Opus Iii-Vii is developing and marketing. Opus Iii-Vii doesn't have any recent trademark applications, indicating Opus Iii-Vii is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
RXCAREASSURANCE business management, business consulting, marketing, advertising and promotional services for the pharmacy industry; business consulting services in the field of medication management by care facilities; procurement, namely, purchasing pharmacy supplies for others	04/29/2010
RXCAREASSURANCE POWERED BY OPUS Business management, business consulting, marketing, advertising and promotional services for the pharmacy industry; business consulting services in the field of medication management by care facilities; procurement, namely, purchasing pharmacy supplies for others	01/30/2009
EZ FILLER Plastic medication containers	02/06/2006

See all trademarks and details in the Full Report.

Market Share of Opus Iii-Vii's Largest Competitors

A competitive analysis shows these companies are in the same general field as Opus Iii-Vii, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Opus Iii-Vii. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ALI HOLDINGS	Omaha, NE	100
ABS	Omaha, NE	46
OPUS III-VII	Omaha, NE	9
FITLIFE BRANDS	Omaha, NE	8

Future Competition: Opus Iii-Vii's Fastest Growing Competitors

These companies are in the same general field as Opus Iii-Vii and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)